Rating Change
Wedbush reiterated its Outperform rating on Xencor, Inc. (NASDAQ:XNCR) on October 21, 2026.
Wedbush reiterated its Outperform rating on Xencor, Inc. (NASDAQ:XNCR) on October 21, 2026.

At publication ·
Xencor, Inc. (NASDAQ:XNCR) · reiterate
At a glance
Wedbush reiterated its Outperform rating on Xencor, Inc. (NASDAQ:XNCR) on October 21, 2026.
Xencor, Inc. operates in the Healthcare sector. The stock currently trades at $24.88 with a market capitalization of $1.2B. The stock has gained 68.9% over the past 52 weeks.
Analyst coverage from Wedbush provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Xencor, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 21, 2026 | Wedbush | Outperform | N/A |
| Sep 28, 2026 | Truist Securities | Buy | N/A |
| Sep 21, 2026 | B of A Securities | Neutral | N/A |
| Sep 11, 2026 | Barclays | Overweight | N/A |
| Sep 03, 2026 | JP Morgan | Neutral | N/A |
Related Tools: Analyst Ratings Dashboard | View XNCR Stock Page
A rating of Outperform from Wedbush reflects the analyst's outlook on Xencor, Inc. (NASDAQ:XNCR). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the XNCR forecast page.
Current market data
NASDAQ · XNCR
$30.64
Up: +$0.98 · +3.30%
Live quote updated
Keep reading